Analysts Are Bullish on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), Madrigal Pharmaceuticals (MDGL)
D.A. Davidson Sticks to Their Hold Rating for Prestige Consumer Healthcare (PBH)
Analysts Offer Insights on Consumer Goods Companies: Prestige Consumer Healthcare (PBH) and Beyond Meat (BYND)
Canaccord Genuity Sticks to Its Buy Rating for Prestige Consumer Healthcare (PBH)
DA Davidson Reiterates Neutral on Prestige Consumer, Maintains $60 Price Target
Prestige Consumer Healthcare (PBH) Was Upgraded to a Hold Rating at D.A. Davidson
National Bank Notes Progress by Premium Brands Holdings, Cuts Price Target on Higher Leverage
D.A. Davidson Keeps Their Hold Rating on Prestige Consumer Healthcare (PBH)
DA Davidson Reiterates Neutral on Prestige Consumer, Maintains $60 Price Target
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Prestige Consumer Healthcare (PBH) and Quest Diagnostics (DGX)
National Bank Maintains Rating, Price Target on Premium Brands Following 'Adequate' Q4 Results, 'Solid' Outlook
RBC Capital Maintains Sector Perform on Prestige Consumer, Lowers Price Target to $104
Prestige Consumer Analyst Ratings
Oppenheimer Maintains Outperform on Prestige Consumer, Lowers Price Target to $71
Oppenheimer Adjusts Prestige Consumer Healthcare's Price Target to $71 From $72, Maintains Outperform Rating
National Bank Previews Premium Brands Holdings' Q4 Results; Price Target Raised
Prestige Consumer Analyst Ratings
Oppenheimer Maintains Outperform on Prestige Consumer, Raises Price Target to $72
Prestige Consumer Analyst Ratings
Canaccord Genuity Initiates Coverage On Prestige Consumer With Buy Rating, Announces Price Target of $71
No Data